Arlou K. Angeles
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Low-coverage whole genome sequencing of cell-free DNA to predict and track immunotherapy response in advanced non-small cell lung cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 13, 2024
Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re-radiotherapy.
Journal: International journal of cancer
Published: May 17, 2024
Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer.
Journal: Cancers
Published: November 17, 2022
Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients.
Journal: Clinical epigenetics
Published: September 29, 2022
Integrated circulating tumour DNA and cytokine analysis for therapy monitoring of ALK-rearranged lung adenocarcinoma.
Journal: British journal of cancer
Published: August 29, 2022
Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors.
Journal: Frontiers in oncology
Published: August 03, 2022
Earlier extracranial progression and shorter survival in ALK-rearranged lung cancer with positive liquid rebiopsies.
Journal: Translational lung cancer research
Published: June 24, 2021
Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA.
Journal: EBioMedicine
Published: June 05, 2020
The ERG-Regulated LINC00920 Promotes Prostate Cancer Cell Survival via the 14-3-3ε-FOXO Pathway.
Journal: Molecular cancer research : MCR
Published: January 08, 2020
Last Updated: 09/26/2026